As of 2026-09-17, the Fair Value of Atara Biotherapeutics Inc (ATRA) is -46.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.71 USD, the upside of Atara Biotherapeutics Inc is -576.87%.
With the market price of 9.71 USD and our fair value calculation, Atara Biotherapeutics Inc (ATRA) is not a good investment. Investing in Atara stocks now will result in a potential loss of 576.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -340.14 | -228.30 | -276.13 | -85.40 | 32.69 | -179.46 |
| YoY growth | -10.93% | 32.88% | -20.95% | 69.07% | 138.28% | 41.67% |
| Market Cap (mil) | 87.49 |
| P/E | |
| Forward P/E | 250.32x |
| EPS | -1.85 |
| Avg earnings growth rate | 41.67% |
| TTM earnings | -16.69 |